Oxyphenbutazone
羟布宗
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameOxyphenbutazone
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved Indications +[4]
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1960/12/21
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesCspc Ouyi Pharmaceutical Co LtdKpc Pharmaceuticals Inc
Inactive CompaniesNovartis Pharma Ag
Active Indications
Inactive Indications